(株)ヘリオスの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4593/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2019/04/12 | 日証協 | 654,152株 | +5.27% | 214,827株 | +16.42% | 583,666株 | +1.25% | 44,000株 | +21.21% |
2019/04/05 | 日証協 | 621,422株 | +1.01% | 184,522株 | +154.16% | 576,440株 | +2.59% | 36,300株 | -30.19% |
2019/03/29 | 日証協 | 615,222株 | +3.29% | 72,600株 | +88.77% | 561,893株 | +6.96% | 52,000株 | +51.53% |
2019/03/22 | 日証協 | 595,620株 | +5.09% | 38,459株 | -3.47% | 525,342株 | +2.88% | 34,316株 | +33.99% |
2019/03/15 | 日証協 | 566,779株 | -3.83% | 39,841株 | -46.77% | 510,637株 | -4.6% | 25,610株 | -26.41% |
2019/03/08 | 日証協 | 589,379株 | -4.66% | 74,841株 | -32.88% | 535,237株 | -1.82% | 34,800株 | -56.93% |
2019/03/01 | 日証協 | 618,179株 | +9.93% | 111,500株 | +3.95% | 545,135株 | +5.07% | 80,805株 | +80.95% |
2019/02/22 | 日証協 | 562,339株 | -7.52% | 107,268株 | +159.73% | 518,835株 | -6.17% | 44,657株 | +77.19% |
2019/02/15 | 日証協 | 608,079株 | -10.72% | 41,300株 | -85.2% | 552,943株 | -6.65% | 25,203株 | -48.48% |
2019/02/08 | 日証協 | 681,120株 | +6.91% | 279,141株 | -58.23% | 592,352株 | +2.27% | 48,919株 | -81.01% |
2019/02/01 | 日証協 | 637,079株 | +69.25% | 668,283株 | +180.61% | 579,222株 | +13.78% | 257,605株 | +136.99% |
2019/01/25 | 日証協 | 376,417株 | +31.84% | 238,154株 | +159.49% | 509,057株 | +2.83% | 108,700株 | +175.78% |
2019/01/18 | 日証協 | 285,518株 | +12.11% | 91,777株 | +38.77% | 495,024株 | +3.75% | 39,415株 | -20.73% |
2019/01/11 | 日証協 | 254,679株 | -18.85% | 66,138株 | +5606.47% | 477,115株 | +2.56% | 49,725株 | +255.18% |
2019/01/04 | 日証協 | 313,820株 | 0% | 1,159株 | -97.66% | 465,222株 | +2.85% | 14,000株 | -75.57% |
2018/12/28 | 日証協 | 313,820株 | -51.3% | 49,427株 | +25.75% | 452,337株 | -1.09% | 57,307株 | +137.79% |
2018/12/21 | 日証協 | 644,345株 | -4.58% | 39,307株 | -89.14% | 457,306株 | -4.59% | 24,100株 | -7.31% |
2018/12/14 | 日証協 | 675,245株 | +4.94% | 362,045株 | -5.33% | 479,306株 | +0.84% | 26,000株 | -4.06% |
2018/12/07 | 日証協 | 643,445株 | +5.06% | 382,445株 | -41.81% | 475,306株 | +0.15% | 27,100株 | -37.32% |
※株式分割は考慮していませんのでご注意ください。
Page Top